Annette Snejbjerg Bartels
Biomedical Laboratory Scientist
Molecular and Cellular Pharmacology
Jagtvej 160, København Ø
1 - 1 out of 1Page size: 10
- Published
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group
Jørgensen, C. L. T., Bjerre, C. A., Ejlertsen, Bent Laursen, Bjerre, K. D., Balslev, E., Bartels, Annette Snejbjerg, Brünner, N. & Nielsen, D. L., 2014, In: B M C Cancer. 14, 14 p., 360.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 6090964
Most downloads
-
865
downloads
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
850
downloads
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
688
downloads
Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
Research output: Contribution to journal › Journal article › Research › peer-review
Published